Enriched blood and nasal polyp ILC2 cultured with TNF demonstrated a time- and dose-dependent production of IL-5 and IL-13, which was further enhanced in the presence of TSLP or IL-33 in vitro. The gene discussed is TSLP; the disease is nasal cavity polyp.